Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational studyANNALS OF MEDICINE, 2025, v.57 no.1, 2428431
Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinomaScientific Reports, 2024, v.14 no.1, 15405
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort studyeClinicalMedicine, 2024, v.73, 102671
Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinomaInternational journal of surgery (London, England), 2024, v.110 no.2, 1008-1018
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis BJournal of Hepatology, 2024, v.80 no.1, 20-30
Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle ModificationMetabolites, 2023, v.13 no.3, 444
Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trialTrials, 2023, v.24 no.1, 490
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational StudyThe American journal of gastroenterology, 2023, v.118 no.11, 1963-1972
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2023, v.21 no.9, 2298-2.31E21
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis BJOURNAL OF HEPATOLOGY, 2022, v.76 no.2, 311-318
Association of Chronic Hepatitis B Infection and Antiviral Treatment with the Development of the Extrahepatic Malignancies: A Nationwide Cohort StudyJournal of Clinical Oncology, 2022, v.392, 1285
Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2022
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis BClinical Gastroenterology and Hepatology, 2022, v.20 no.6, 1343-1.35E19
Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute DeteriorationJournal of Clinical Medicine, 2022, v.11 no.9, 2463
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyDigestive Diseases and Sciences, 2021, v.66 no.7, 2427-2438
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular CarcinomaYONSEI MEDICAL JOURNAL, 2021 , 12-20
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosisCLINICAL AND MOLECULAR HEPATOLOGY, 2021, v.27 no.4, 535-552
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic functionBMC CANCER, 2020, v.20 no.1, 504
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyGUT, 2020, v.69 no.12, 2214-2222
Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver diseaseScientific Reports, 2020, v.10 no.1, 17491
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular CarcinomaKOREAN JOURNAL OF RADIOLOGY, 2019, v.20 no.7, 1042-
Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varicesJOURNAL OF HEPATOLOGY, 2019, v.70 no.3, 412-422
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trialJOURNAL OF HEPATOLOGY, 2019, v.70 no.4, 684-691
The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial ChemoembolizationJournal of Vascular and Interventional Radiology, 2019, v.30 no.3, 358-369
Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma: A multi-cohort studyCancers, 2019, v.11 no.11, 1721
A Model for Adaptive Decision Making of 'Ablate-and-Wait' Versus Transplantation in Patients with Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2018, v.52 no.7, 655-661
Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trialTRIALS, 2018, v.19, 696
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic areaALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, v.47 no.11, 1490-1501
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort studyBMC CANCER, 2018, v.18
Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter studyJOURNAL OF MEDICAL VIROLOGY, 2018, v.90 no.10, 1593-1603
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with SorafenibCANCER RESEARCH AND TREATMENT, 2018, v.50 no.2, 366-373
Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directionsTherapeutic Advances in Gastroenterology, 2017, v.10 no.10, 805-814
Noninvasive prediction of hemodynamic response to carvedilol therapy for primary prophylaxis in cirrhotic patients with esophageal varices: a prospective studyJOURNAL OF HEPATOLOGY, 2017, v.66 no.1, S47-S47
A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort StudyHEPATOLOGY, 2016, v.63 no.1 SUPP, 634A-634A
Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction SyndromeMEDICINE, 2016, v.95 no.2, e2454
Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholismJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.2, 427-433
Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.4, 814-821
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!Gut and Liver, 2016, v.10 no.6, 869
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!GUT AND LIVER, 2016, v.10 no.6, 869-870
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan CriteriaANNALS OF SURGERY, 2016, v.263 no.5, 842-850
Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric AssayGUT AND LIVER, 2015, v.9 no.5, 657-664
Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis CJOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, v.49 no.8, 697-704
Reduction of Oxidative Stress Attenuates Lipoapoptosis Exacerbated by Hypoxia in Human HepatocytesINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, v.16 no.2, 3323-3334
The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic PatientsMEDICINE, 2015, v.94 no.24, e1031
[학술지논문] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
JOURNAL OF HEPATOLOGY, 2022, v.76
no.2
, 311-318
SCI
[학술지논문] Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study
JOURNAL OF CLINICAL ONCOLOGY, 2022, v.40
no.29
, 3394-+
SCI
[학술지논문] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, v.20
no.6
, 1343-+
SCIE
[학술지논문] Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
JOURNAL OF CLINICAL MEDICINE, 2022, v.11
no.9
, 2463-2463
SCIE
[학술지논문] Recent advances in nonalcoholic fatty liver disease metabolomics
Clinical and molecular hepatology, 2021, v.27
no.4
, 553-559
SCIE
[학술지논문] Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
Clinical and molecular hepatology, 2020, v.26
no.2
, 238-239
SCIE
[학술지논문] Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease
SCIENTIFIC REPORTS, 2020, v.10
no.1
, 17491-17491